Autonomic Neuropathy
15
1
1
9
Key Insights
Highlights
Success Rate
90% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
6.7%
1 terminated out of 15 trials
90.0%
+3.5% vs benchmark
0%
0 trials in Phase 3/4
22%
2 of 9 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 9 completed trials
Clinical Trials (15)
Vagus Nerve Stimulation for Systemic Lupus Erythematous
Autonomic Small Fiber Neuropathy and Ehlers Danlos Syndromes - Prospective Study and Registry
Metabolic Syndrome and Fall Risk
Diabetic Small Fiber Neuropathy: Clinical, Electrophysiological and Neurosonographic Study
Cardiac Arrhythmias in Greenland
LSFG-SKIN, Laser Speckle Flowgraphy
Diabetic Neuropathy Screening Study 1.1 + Substudy 1.2-1.3-1.4
24-hour Blood Pressure Dynamics and Autonomic Adrenergic Regulation in Type 2 Diabetics
Investigation of the Rewarming og the Fingers After Cooling and the Autonomic Nervous System in Raynaud's Phenomenon
Effects of Feet Mechanical Stimulation on Cardiovascular Autonomic Profile and Inflammation in Parkinson's Disease
Autonomic Manifestations of Testosterone Deficiency in Men
Coronary Blood Flow Regulation During General Anesthesia
Diabetes Peripheral Neuropathy and Small-fibre Nerve Damage: A Comparative Study
A Comparison Between Pupillometry, Heart Rate Variability and Metaiodobenzylguanidine Scintigraphy for the Diagnosis of Early Diabetic Autonomic Neuropathy in Type 1 Diabetes
Autonomic Nervous System Dysfunction and Peripheral Neuropathy in a Cohort of Asymptomatic Juvenile Diabetic Patients (Type I): A Case-Controlled Study